| Ytd | 43.79% | |
| 1y | 79.74% |
| Open | 4.03 | Prev Close | 4.12 | Low | 3.91 | High | 4.21 | Mkt Cap | 57.02M |
| Vol | 144.22K | Avg Vol | 300.85K | EPS | -4.33 | P/E | -0.96 | Forward P/E | -2.64 |
| Beta | 0.27 | Short Ratio | 19.81 | Inst. Own | 53.88% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 4.12 | 200-d Avg | 3.52 | 1yr Est | 34.75 |
HC Wainwright & Co. analyst Robert Burns maintains OnKure Therapeutics (NASDAQ:OKUR) with a B
OnKure Therapeutics NASDAQ: OKUR used a scientific webcast to outline its strategy for developing mu
Gainers Catheter Precision (AMEX:VTAK) shares rose 78.2% to $1.55 during Monday's after-market